Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.57 |
| ▸ | POLB | P06746 | 9/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.57 |
| ▸ | APEX1 | P27695 | 5/20 | 0.57 |
| ▸ | CTDSP1 | Q9GZU7 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 8/20 | 0.57 |
| ▸ | MAPT | P10636 | 6/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 5/20 | 0.54 |
| ▸ | MET | P08581 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31358892 | 0.89 | ALDH1A1 (0.64) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358731 | 0.87 | AKT1 (0.77) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358696 | 0.84 | PTPN5 (0.50) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358769 | 0.82 | SIRT2 (0.66) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358678 | 0.82 | KDM4E (0.70) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358776 | 0.81 | SIRT2 (0.62) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358833 | 0.81 | PIK3CG (0.61) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358693 | 0.81 | AKT1 (0.58) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358688 | 0.80 | HTRA2 (0.66) | AKT1KMT2AALDH1A1POLBKDM4E | |
| SCHEMBL31358841 | 0.80 | AKT1 (0.73) | AKT1KMT2AALDH1A1POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250026741-A1 | INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute | 2025-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026741-A1 | INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF | PTPN18, PTPN7, PTPN1 | AKT1 194/4885KMT2A 1043/4885ALDH1A1 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.